{
  "success": true,
  "enriched": 48,
  "total_entities": 601,
  "by_type": {
    "StudyArm": 5,
    "EligibilityCriterion": 31,
    "Objective": 4,
    "Endpoint": 8
  },
  "enriched_items": [
    {
      "type": "StudyArm",
      "name": "Cohort A",
      "arm_type": "Experimental Arm",
      "nci_code": "C174266"
    },
    {
      "type": "StudyArm",
      "name": "Sub-Cohort B1",
      "arm_type": "Experimental Arm",
      "nci_code": "C174266"
    },
    {
      "type": "StudyArm",
      "name": "Sub-Cohort B2",
      "arm_type": "Experimental Arm",
      "nci_code": "C174266"
    },
    {
      "type": "StudyArm",
      "name": "Sub-Cohort B3",
      "arm_type": "Experimental Arm",
      "nci_code": "C174266"
    },
    {
      "type": "StudyArm",
      "name": "Cohort C",
      "arm_type": "Experimental Arm",
      "nci_code": "C174266"
    },
    {
      "type": "EligibilityCriterion",
      "name": "Histological or cytological confirmation",
      "category": "Inclusion",
      "nci_code": "C25532"
    },
    {
      "type": "EligibilityCriterion",
      "name": "Refractory/relapsed solid tumors",
      "category": "Inclusion",
      "nci_code": "C25532"
    },
    {
      "type": "EligibilityCriterion",
      "name": "Measurable disease",
      "category": "Inclusion",
      "nci_code": "C25532"
    },
    {
      "type": "EligibilityCriterion",
      "name": "ECOG performance status",
      "category": "Inclusion",
      "nci_code": "C25532"
    },
    {
      "type": "EligibilityCriterion",
      "name": "Life expectancy",
      "category": "Inclusion",
      "nci_code": "C25532"
    },
    {
      "type": "EligibilityCriterion",
      "name": "Adequate organ function",
      "category": "Inclusion",
      "nci_code": "C25532"
    },
    {
      "type": "EligibilityCriterion",
      "name": "Recovery from prior therapy toxicities",
      "category": "Inclusion",
      "nci_code": "C25532"
    },
    {
      "type": "EligibilityCriterion",
      "name": "Urinary protein requirement",
      "category": "Inclusion",
      "nci_code": "C25532"
    },
    {
      "type": "EligibilityCriterion",
      "name": "Sex",
      "category": "Inclusion",
      "nci_code": "C25532"
    },
    {
      "type": "EligibilityCriterion",
      "name": "Informed Consent",
      "category": "Inclusion",
      "nci_code": "C25532"
    },
    {
      "type": "EligibilityCriterion",
      "name": "Uncontrolled hypertension",
      "category": "Exclusion",
      "nci_code": "C25370"
    },
    {
      "type": "EligibilityCriterion",
      "name": "Significant bleeding disorders",
      "category": "Exclusion",
      "nci_code": "C25370"
    },
    {
      "type": "EligibilityCriterion",
      "name": "Hepatic impairment",
      "category": "Exclusion",
      "nci_code": "C25370"
    },
    {
      "type": "EligibilityCriterion",
      "name": "Arterial thromboembolic events",
      "category": "Exclusion",
      "nci_code": "C25370"
    },
    {
      "type": "EligibilityCriterion",
      "name": "Congestive heart failure or cardiac arrh",
      "category": "Exclusion",
      "nci_code": "C25370"
    },
    {
      "type": "EligibilityCriterion",
      "name": "Serious concomitant systemic disorder",
      "category": "Exclusion",
      "nci_code": "C25370"
    },
    {
      "type": "EligibilityCriterion",
      "name": "Active infection requiring systemic ther",
      "category": "Exclusion",
      "nci_code": "C25370"
    },
    {
      "type": "EligibilityCriterion",
      "name": "HIV positive participants",
      "category": "Exclusion",
      "nci_code": "C25370"
    },
    {
      "type": "EligibilityCriterion",
      "name": "Chronic active hepatitis B or C",
      "category": "Exclusion",
      "nci_code": "C25370"
    },
    {
      "type": "EligibilityCriterion",
      "name": "Prior or second concurrent primary malig",
      "category": "Exclusion",
      "nci_code": "C25370"
    },
    {
      "type": "EligibilityCriterion",
      "name": "Symptomatic CNS malignancy or metastasis",
      "category": "Exclusion",
      "nci_code": "C25370"
    },
    {
      "type": "EligibilityCriterion",
      "name": "History of GI perforation and/or fistula",
      "category": "Exclusion",
      "nci_code": "C25370"
    },
    {
      "type": "EligibilityCriterion",
      "name": "Serious or non-healing wound, ulcer, or ",
      "category": "Exclusion",
      "nci_code": "C25370"
    },
    {
      "type": "EligibilityCriterion",
      "name": "Chronic therapy with NSAIDs or antiplate",
      "category": "Exclusion",
      "nci_code": "C25370"
    },
    {
      "type": "EligibilityCriterion",
      "name": "Prior treatment with IV ramucirumab",
      "category": "Exclusion",
      "nci_code": "C25370"
    },
    {
      "type": "EligibilityCriterion",
      "name": "Recent participation in clinical study w",
      "category": "Exclusion",
      "nci_code": "C25370"
    },
    {
      "type": "EligibilityCriterion",
      "name": "Tattoos or scars over abdomen interferin",
      "category": "Exclusion",
      "nci_code": "C25370"
    },
    {
      "type": "EligibilityCriterion",
      "name": "Elective or planned major surgery",
      "category": "Exclusion",
      "nci_code": "C25370"
    },
    {
      "type": "EligibilityCriterion",
      "name": "Major blood vessel invasion or encasemen",
      "category": "Exclusion",
      "nci_code": "C25370"
    },
    {
      "type": "EligibilityCriterion",
      "name": "Intratumor cavitation (NSCLC)",
      "category": "Exclusion",
      "nci_code": "C25370"
    },
    {
      "type": "EligibilityCriterion",
      "name": "History of gross hemoptysis (NSCLC)",
      "category": "Exclusion",
      "nci_code": "C25370"
    },
    {
      "type": "Objective",
      "name": "Primary Pharmacokinetic Objective",
      "level": "Trial Primary Objective",
      "nci_code": "C85826"
    },
    {
      "type": "Objective",
      "name": "Primary Safety Objective",
      "level": "Trial Primary Objective",
      "nci_code": "C85826"
    },
    {
      "type": "Objective",
      "name": "Secondary Efficacy Objective",
      "level": "Trial Secondary Objective",
      "nci_code": "C85827"
    },
    {
      "type": "Objective",
      "name": "Exploratory Immunogenicity Objective",
      "level": "Trial Exploratory Objective",
      "nci_code": "C163559"
    },
    {
      "type": "Endpoint",
      "name": "Ramucirumab Ctrough",
      "level": "Primary Outcome Measure",
      "nci_code": "C98772"
    },
    {
      "type": "Endpoint",
      "name": "Ramucirumab AUC",
      "level": "Primary Outcome Measure",
      "nci_code": "C98772"
    },
    {
      "type": "Endpoint",
      "name": "Ramucirumab Cmax",
      "level": "Primary Outcome Measure",
      "nci_code": "C98772"
    },
    {
      "type": "Endpoint",
      "name": "Treatment-Emergent Adverse Events",
      "level": "Primary Outcome Measure",
      "nci_code": "C98772"
    },
    {
      "type": "Endpoint",
      "name": "Injection Site Reactions",
      "level": "Primary Outcome Measure",
      "nci_code": "C98772"
    },
    {
      "type": "Endpoint",
      "name": "Progression-Free Survival",
      "level": "Secondary Outcome Measure",
      "nci_code": "C98781"
    },
    {
      "type": "Endpoint",
      "name": "Overall Survival",
      "level": "Secondary Outcome Measure",
      "nci_code": "C98781"
    },
    {
      "type": "Endpoint",
      "name": "Immunogenicity Assessment",
      "level": "Exploratory Outcome Measure",
      "nci_code": "C98724"
    }
  ],
  "cache_stats": {
    "total_entries": 50,
    "fresh_entries": 50,
    "stale_entries": 0,
    "cache_file": "C:\\Users\\panik\\Documents\\GitHub\\Protcol2USDMv3\\core\\evs_cache\\nci_codes.json"
  }
}